top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

McGA FlowDown™ Analysis

  • Comparative clinical landscaping and competitive analyses

  • NCCN Guidelines and Compendium Positioning Strategy

  • NCCN Submission Letters (e.g., on-label, off-label)

  • Other CMS-recognized compendia and pathways

  • Clinical data modeling and forecasting regarding payer response and coverage

  • Stakeholder messaging and value messaging strategy

  • Compendia strategy and submissions

  • Navigating coverage policy and utilization management

  • Pipeline and pre-launch strategy, direction, and positioning for oncology and specialty products

Payer and Coverage Strategy

  • Comparative clinical landscaping and competitive analyses

  • NCCN Guidelines and Compendium Positioning Strategy

  • NCCN Submission Letters (e.g., on-label, off-label)

  • Other CMS-recognized compendia and pathways

  • Clinical data modeling and forecasting regarding payer response and coverage

McGA FlowDown™ Analysis

  • Payer-based forecast scenarios and revenue projections

  • Alternative Payment Models (APMs) portfolio impact modeling

  • Models and scenario analyses for financial impact of policy (e.g., value-based reimbursement)

  • Health policy impact assessment and strategy

  • Impact of Oncology Value Metrics frameworks

  • Strategic health economics tools (e.g., "Retail vs. Real Price" and alternatives to the QALY)

Economic/Financial Policy and Strategy

  • Price/value justification and policy presentation

  • Understanding impact of utilization management tools (precert, step therapy, tiering) on specific products and forecasting impact

  • Payment method changes and impact on sales (340b, bundled payments)

  • Modeling impact of policy changes on specific products, therapeutic areas, or portfolio-wide (including key pipeline agents)

Forecasting, Modeling, and Value Impact Analysis

  • Advisory Boards, Summits, Focus Groups, and interview series with national thought leaders from payer, provider, patient, and policy spheres

Advisory Boards and Market Research Insights

  • Competitive and Comparative decision-making intelligence

  • Understanding and monitoring data and product positioning in EMRs/EHRs, order sets, and decision-assist tools

  • Data analysis and strategy for indication expansion

  • Long term data collection and analysis in Phase IV to enhance positioning throughout product life-cycle

  • Strategy for longitudinal databases and big data

Data, Evidence, and Competitive Positioning

  • Comprehensive ongoing corporate (e.g., national sales force) training and education

  • Cross-functional alignment training and education on policy, payer strategy, and market access

  • Full-day workshops on guideline (e.g., NCCN), compendia, and pathways processes, positioning, and implications

  • Strategic publication planning

  • Key Opinion Organization (KOO)/Key Opinion Leader (KOL) relationship mapping, descriptions, internal assignments, and stakeholder targeted data information packets

  • Prospective outlook on strategic planning opportunities for guidelines and compendia

Training, Education, and Publications

bottom of page